Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system

Gene Therapy advance online publication, July 29, 2010. doi:10.1038/gt.2010.102

Authors: G-J Ye, M M Scotti, J Liu, L Wang, D R Knop & G Veres

Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia

Gene Therapy advance online publication, July 29, 2010. doi:10.1038/gt.2010.101

Authors: W-B Pyun, W Hahn, D-S Kim, W-S Yoo, S-D Lee, J-H Won, B-S Rho, Z-Y Park, J-M Kim & S Kim

Efficient delivery of DNA vaccines using human papillomavirus pseudovirions

Gene Therapy advance online publication, July 29, 2010. doi:10.1038/gt.2010.106

Authors: S Peng, A Monie, T H Kang, C-F Hung, R Roden & T-C Wu

Winners and losers and oncolytic adenoviruses: who should be down in the mouth?

Gene Therapy advance online publication, July 29, 2010. doi:10.1038/gt.2010.98

Author: K J Harrington

Carving the CAR

Gene Therapy advance online publication, July 29, 2010. doi:10.1038/gt.2010.96

Authors: S R Riddell & U Protzer

Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy

Gene Therapy advance online publication, July 22, 2010. doi:10.1038/gt.2010.100

Authors: T Cherry, S L Longo, Z Tovar-Spinoza & D E Post

Identification and removal of colanic acid from plasmid DNA preparations: implications for gene therapy

Gene Therapy advance online publication, July 22, 2010. doi:10.1038/gt.2010.97

Authors: P Firozi, W Zhang, L Chen, F A Quiocho, K C Worley & N S Templeton

Progress and prospects: Foamy virus vectors enter a new age

Gene Therapy advance online publication, July 15, 2010. doi:10.1038/gt.2010.95

Authors: O Erlwein & M O McClure

Soluble TNF-α receptor secretion from healthy or dystrophic mice after AAV6-mediated muscle gene transfer

Gene Therapy advance online publication, July 1, 2010. doi:10.1038/gt.2010.94

Authors: G Moulay, C Masurier, P Bigey, D Scherman & A Kichler

Addition of adenoviral vector targeting of chemotherapy to the MUC-1/ecdCD40L VPPP vector prime protein boost vaccine prolongs survival of mice carrying growing subcutaneous deposits of Lewis lung cancer cells

Gene Therapy advance online publication, July 1, 2010. doi:10.1038/gt.2010.93

Authors: H Akbulut, Y Tang, K G Akbulut, J Maynard & A Deisseroth